NEW YORK, Aug. 26, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE MKT: AMPE) between December 14, 2017 through August 7, 2018, both dates inclusive (the "Class Period"). The lawsuit seeks to recover Ampio shareholders' investment losses.